MRPL14

Across TCGA pan-cancer cohorts, MRPL14 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated MRPL14 data layer compared with 29 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MRPL14 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MRPL14 expression acts as an unfavorable survival marker.

UCEC are the cancer types where MRPL14 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	0.061	0.588	.018	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MRPL14–UCEC (OS)

Open the UCEC breakdown →